These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27055583)

  • 1. Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects.
    Oray M; Meese H; Foster CS
    Expert Rev Clin Immunol; 2016 Aug; 12(8):827-37. PubMed ID: 27055583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy insight: scleritis and its relationship to systemic autoimmune disease.
    Smith JR; Mackensen F; Rosenbaum JT
    Nat Clin Pract Rheumatol; 2007 Apr; 3(4):219-26. PubMed ID: 17396107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Approach for the Diagnosis and Management of Noninfective Scleritis.
    Dutta Majumder P; Agrawal R; McCluskey P; Biswas J
    Asia Pac J Ophthalmol (Phila); 2020 Dec; 10(2):212-223. PubMed ID: 33290287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleritis: Immunopathogenesis and molecular basis for therapy.
    Wakefield D; Di Girolamo N; Thurau S; Wildner G; McCluskey P
    Prog Retin Eye Res; 2013 Jul; 35():44-62. PubMed ID: 23454614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of scleritis: current paradigms and future directions.
    Beardsley RM; Suhler EB; Rosenbaum JT; Lin P
    Expert Opin Pharmacother; 2013 Mar; 14(4):411-24. PubMed ID: 23425055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Episcleritis and scleritis. An overview of modern diagnostic and therapeutic concepts].
    Denk PO; Thiel HJ; Zierhut M
    Klin Monbl Augenheilkd; 1997 Sep; 211(3):140-50. PubMed ID: 9445894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Scleritis: when might a systemic disease be involved?].
    Gabison E; Hoang-Xuan T
    J Fr Ophtalmol; 2010 Oct; 33(8):593-8. PubMed ID: 20728244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subretinal mass as a presenting sign of posterior scleritis: a case report.
    Wang JK; Lai PC; Yang CH
    Kaohsiung J Med Sci; 2003 Oct; 19(10):522-5. PubMed ID: 14620679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conjunctivitis, episcleritis and scleritis].
    Robin H
    Rev Prat; 1999 Nov; 49(18):1969-75. PubMed ID: 10626480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveitis.
    Dunn JP
    Prim Care; 2015 Sep; 42(3):305-23. PubMed ID: 26319340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Posterior scleritis--diagnostic difficulties--a case report].
    Stan C; Bedeoan S
    Oftalmologia; 2005; 49(4):35-7. PubMed ID: 16524123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Scleritis and episcleritis].
    Perray L; Ungerer L; Chazal T; Monnet D; Brézin A; Terrier B
    Rev Med Interne; 2023 Dec; 44(12):646-655. PubMed ID: 37344292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleritis: Differentiating infectious from non-infectious entities.
    Murthy SI; Sabhapandit S; Balamurugan S; Subramaniam P; Sainz-de-la-Maza M; Agarwal M; Parvesio C
    Indian J Ophthalmol; 2020 Sep; 68(9):1818-1828. PubMed ID: 32823398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis-associated necrotizing scleritis and peripheral ulcerative keratitis treated successfully with infliximab.
    Atchia II; Kidd CE; Bell RW
    J Clin Rheumatol; 2006 Dec; 12(6):291-3. PubMed ID: 17149060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective.
    Stem MS; Todorich B; Faia LJ
    J Ocul Pharmacol Ther; 2017 May; 33(4):240-246. PubMed ID: 28355124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Posterior scleritis: six case reports].
    Ladjimi A; Messaoud R; Attia S; Jenzri S; Zaouali S; Chaouch K; Bhouri L; Jelliti B; Khairallah M
    J Fr Ophtalmol; 2003 Oct; 26(8):845-52. PubMed ID: 14586229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.
    Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I
    Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular scleritis: case report involving immunosuppressive therapy.
    Niemann KK; Bartlett JD; Heck LW; McCollum CJ
    J Am Optom Assoc; 1997 Dec; 68(12):782-7. PubMed ID: 9635385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scleritis therapy.
    Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
    Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
    Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
    Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.